Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythroid involvement in CD36 deficiency.

K Toba1, H Hanawa, K Watanabe

  • 1First Department of Internal Medicine, Niigata University, Niigata City, Japan. tobaken@med.niigata-u.ac.jp

Experimental Hematology
|October 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of raising the upper limb of the non-rising side when performing rising movements from bed.

Scientific reports·2023
Same author

TRENDS IN THE PREVALENCE OF FRAILTY IN JAPAN: A META-ANALYSIS FROM THE ILSA-J.

The Journal of frailty & aging·2021
Same author

Usefulness of Muscle Synergy Analysis in Individuals With Knee Osteoarthritis During Gait.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2020
Same author

Predictive Ability of Seven Domains of the Kihon Checklist for Incident Dependency and Mortality.

The Journal of frailty & aging·2019
Same author

Primary Thrombocythemia in Japan: A Survey of 225 Patients.

Leukemia & lymphoma·2016
Same author

A New Grip Strength Measuring Device for Detailed Evaluation of Muscle Contraction among the Elderly.

The Journal of frailty & aging·2016
Same journal

Multidisciplinary Characterization of Rare MPL Y591 and R592 Variants in Myeloid Disorders: From Clinical Correlation and Literature-Based Evidence to In Silico Predictors and Structural Bioinformatics.

Experimental hematology·2026
Same journal

Integrin alpha 4 inhibition prolongs the survival of NSG mice engrafted with CD19-negative post-CART19 relapsed B-ALL.

Experimental hematology·2026
Same journal

RNA Binding Protein PCBP1 Functions in the Endothelial-to-Hematopoietic Transition During Hematopoietic Stem Cell Formation.

Experimental hematology·2026
Same journal

Image-enabled cell sorting permits prospective isolation of primitive hematopoietic stem cell subsets with distinct functional potential.

Experimental hematology·2026
Same journal

Inhibition of MLLT1 Limits Growth of KMT2A::AFF1 Leukemias Without Killing Healthy Hematopoietic Stem Cells.

Experimental hematology·2026
Same journal

Adaptive Immune Remodeling in Sickle Cell Disease: Linking Hemolysis-Driven Inflammation to Immune Dysfunction.

Experimental hematology·2026
See all related articles

CD36 deficiency shows distinct patterns in erythroblasts, revealing new subtypes and suggesting a common mechanism for type II deficiency, possibly related to glycosylation. This impacts understanding of platelet CD36 disorders.

Area of Science:

  • Hematology
  • Molecular Biology
  • Immunology

Background:

  • CD36 molecule is crucial and expressed in various blood cells and tissues.
  • Platelet CD36 deficiency presents as Type I (absent on monocytes) and Type II (present on monocytes).
  • The role of the erythroid lineage in CD36 deficiency remains unclear.

Purpose of the Study:

  • To investigate the phenotype and RNA expression of CD36 in the erythroid lineage.
  • To clarify the involvement of erythroblasts in CD36 deficiency.
  • To identify heterogeneity within CD36 deficiency types.

Main Methods:

  • Examined CD36 expression in 296 patients with cardiovascular diseases.
  • Analyzed bone marrow samples from Type I and Type II CD36 deficiency patients.

Related Experiment Videos

  • Investigated CD36 mRNA expression in burst-forming unit-erythroid (BFU-E) using RT-PCR.

    • Main Results:

    • CD36 was absent in erythroblasts of all Type I deficiency patients.
    • Erythroblasts showed CD36 presence in most Type II patients (Type IIa), but absence in one (Type IIb).
    • CD36 mRNA was detected in BFU-E from normal and CD36-deficient individuals, including Type IIb.

    Conclusions:

    • Findings indicate significant heterogeneity among CD36-deficient individuals.
    • A common underlying mechanism for Type II CD36 deficiency, potentially glycosylation abnormality, is suggested.
    • Erythroid lineage involvement varies across CD36 deficiency types.